Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Latest late clinical blogs

Meet our experts at the following events

All late clinical resources

Go beyond basic validation: Achieve submission-ready datasets with Pinnacle 21 Enterprise

CDISC, Certara Products - Pinnacle 21, Fact Sheet

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

AI & Machine Learning, Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Certara Services, Clinical Pharmacology, Drug Development, Infectious Disease, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Publication

Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical data [Korean Webinar]

Certara Products - Pinnacle 21, Certara Products - SEND Explorer, Data Standards, Webinar

EANM 2026

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Webinar

Model smarter, not harder: How Phoenix Cloud puts the science back at the center of modeling

Certara Products - Phoenix, Model Informed Drug Development, Modeling and Simulation - PK/PD, Blog

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication

When to conduct hepatic impairment studies and when modeling may be enough

Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Blog

AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium

Market Access, Market Access and Pricing, Modeling and Simulation, Blog

Cracking the code on NCA: How Pinnacle 21 helps de-risk PK analyses

Certara Products - Pinnacle 21, Modeling and Simulation - PK/PD, Blog

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Certara Products - Simcyp, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), On-Demand Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.